Obesity promotes gastric cancer metastasis via diacylglycerol acyltransferase 2-dependent lipid droplets accumulation and redox homeostasis

Shuai Li,Teng Wu,Yun-Xin Lu,Jin-Xiang Wang,Feng-Hai Yu,Mei-Zhu Yang,Yi-Jia Huang,Zhi-Jing Li,Sen-Lan Wang,Ling Huang,Lei Lu,Tian Tian
DOI: https://doi.org/10.1016/j.redox.2020.101596
IF: 11.4
2020-09-01
Redox Biology
Abstract:<p>Experimental and molecular epidemiological studies indicate important roles for adipose tissue or high-fat diet (HFD) in tumor growth and metastasis. Gastric cancer (GC) possesses a metastatic predilection for the adipocyte-rich peritoneum. However, the precise molecular relevance of HFD in the peritoneal metastasis of GC remains unclear. Here, we showed that HFD causes obvious fat accumulation and promotes peritoneal dissemination of GC <em>in vivo</em>. Peritoneum-derived adipocytes induces robust lipid droplet (LD) accumulation and fatty acid oxidation in GC cells through transcriptional upregulation of DGAT2 in a C/EBPα-dependent manner and prevents anoikis during peritoneal dissemination. Treatment of GC cells with FAs or coculture with adipocytes induces intracellular formation of LDs and production of NADPH to overcome oxidative stress <em>in vitro</em>. Importantly, overexpression of DGAT2 was identified as an independent predictor of poor survival that promotes lung and peritoneal metastasis of GC, and genetic or pharmacological inhibition of DGAT2, via disruption of lipid droplet formation in a lipid-rich environment, enhances the sensitivity of GC to anoikis <em>in vitro</em> and inhibits peritoneal metastasis <em>in vivo</em>. Overall, our findings highlight the notion that DGAT2 may be a promising therapeutic target in GC with peritoneal implantation and provide some evidence for uncovering the link between obesity and tumor metastasis.</p>
biochemistry & molecular biology
What problem does this paper attempt to address?